Urgent Public Health COVID-19 Studies

If you are a journalist and are interested in one of the nationally prioritised studies listed below, please contact the Press Office of the funding organisation.

BASIL+BothNIHR Central Commissioning Facility (CCF)Tees, Esk and Wear Valleys NHS Foundation TrustOpen28 May 2020
PRONTOBothNIHRUniversity of LiverpoolOpen08 December 2020
A phase II study of a candidate COVID-19 vaccine in children (COV006)BothNIHR Central Commissioning Facility (CCF)not availableOpen17 February 2021
REMAP-CAPInterventionalEuropean CommissionUniversity Medical Centre Utrecht (Netherlands)Open 27 March 2020
Repair of ARDS by Stromal Cell Administration (REALIST)InterventionalPublic Health Agency for Northern Ireland; Wellcome TrustBelfast Health & Social Care TrustSuspended02 April 2020
A phase I/II trial of a candidate COVID-19 vaccine (COV001)InterventionalNIHR/UKRIUniversity of OxfordClosed11 March 2020
RECOVERY trialInterventionalNIHR/UKRIUniversity of OxfordOpen11 March 2020
PRINCIPLEInterventionalNIHR/UKRIUniversity of OxfordOpen11 March 2020
5774 Safety & Antiviral Activity of Remdesivir for moderate COVID-19InterventionalGilead Sciences IncGilead Sciences IncClosed25 March 2020
5773 Safety and Antiviral Activity of Remdesivir for severe COVID-19InterventionalGilead Sciences IncGilead Sciences IncClosed25 March 2020
A study to evaluate TCZ in patients with severe COVID-19 PneumoniaInterventionalF. Hoffmann-La Roche LtdF. Hoffmann-La Roche LtdClosed26 March 2020
Adaptive COVID-19 Treatment Trial (ACTT)InterventionalNational Institutes of Health (NIH), United StatesUniversity of Minnesota (USA)Closed27 March 2020
COPCOV trialInterventionalWellcome TrustUniversity of OxfordClosed30 March 2020
CANCOVIDInterventionalNovartisNovartisClosed06 April 2020
RUXCOVIDInterventionalNovartisNovartisClosed06 April 2020
ILIAD 7InterventionalRevImmuneRevImmuneOpen06 April 2020
RECOVERY - Respiratory SupportInterventionalDepartment of Health and Social CareUniversity of WarwickOpen13 April 2020
DeVENTInterventionalEuropean CommissionImperial College of Science, Technology and MedicineOpen 13 April 2020
STOP-COVID19InterventionalInsmed IncUniversity of DundeeClosed21 April 2020
Investigating a Vaccine Against COVID-19 (COV002)InterventionalNIHR/UKRIUniversity of OxfordClosed30 April 2020
OSCARInterventionalGlaxoSmithKlineGlaxoSmithKlineClosed07 May 2020
CATALYSTInterventionalnot availableUniversity of BirminghamOpen11 May 2020
TACTIC-R InterventionalEly Lilly and Company; Alexion PharmaceuticalsCambridge University Hospitals NHS Foundation TrustOpen11 May 2020
DEFINEInterventionalnot availablenot availableOpen11 May 2020
COG-UK HOCIInterventionalUK Research and Innovation (UKRI)University College LondonOpen11 May 2020
COVAC 1InterventionalNIHR/UKRIImperial College LondonClosed20 May 2020
BASIL-C19InterventionalNIHRTees, Esk and Wear Valleys NHS Foundation TrustClosed28 May 2020
REPROVIDEInterventionalNIHRUniversity of BristolOpen28 May 2020
Humoral Immune Correlates for COVID19InterventionalNIHR/UKRIRoyal Papworth Hospital NHS Foundation TrustOpen01 July 2020
COVID-19 Germ Defence ImplementationInterventionalNIHR/UKRIUniversity of BristolOpen10 August 2020
A Phase 3 COVID-19 Vaccine StudyInterventionalJanssen-Cilag LtdJanssen-Cilag LtdOpen28 August 2020
A trial to evaluate SARS-CoV-2 Recombinant Nanoparticle vaccineInterventionalNOVAVAX, INC.NOVAVAX, INC.Closed28 August 2020
PROVENTInterventionalAstraZenecaAstraZenecaClosed09 October 2020
STORM CHASERInterventionalAstraZenecaAstraZenecaOpen19 October 2020
ADAPT-Sepsis TrialInterventionalNIHRUniversity of ManchesterOpen19 October 2020
SARS-COV-2 Virus Vaccine (VLA2001) against COVID-19InterventionalValnevaValnevaClosed29 October 2020
Phase III trial of inhaled anti-viral (SNG001) for SARS-CoV-2InterventionalSynairgen Research LimitedSynairgen Research LimitedOpen14 October 2020
CORONAVITInterventionalPHARMA NORD (UK) LIMITEDQueen Mary University of LondonClosednot available
SG016 Home StudyInterventionalnot availableSynairgen Research LimitedClosed13 January 2021
A Randomized, Double-blind, Placebo-controlled Phase 2a Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults Aged 18 to 55 Years Inclusive and Adults Aged 65 Years and Older and to Evaluate 2 Dose Levels of AInterventionalnot availableJanssenIn Setup13 January 2021
Non-inferiority study comparing immunogenicity against COVID-19 of VLA2001 with [ACTIVE COMPARATOR]Interventionalnot availableValnevaIn Setup13 January 2021
Com-COV: Comparing COVID-19 Vaccine Schedule CombinationsInterventionalDepartment for Business, Energy and Industrial StrategyUniversity of OxfordOpen13 January 2021
SPIKE-1InterventionalLIFEARCCancer Research UKOpen01 February 2021
CoVLPInterventionalMedicagoMedicagoIn Setup21 December 2020
Study of the safety of & response to a COVID-19 vaccine in pregnancyInterventionalJanssen-Cilag LtdJanssen-Cilag LtdIn Setup17 February 2021
FLU-CATs : Evaluation and refinement of pandemic influenza community assessment toolsObservationalNIHRUniversity of LiverpoolOpen20 March 2020
Clinical Characterisation Protocol (CCP) for Severe Emerging InfectionObservationalWellcome TrustUniversity of OxfordOpen24 January 2020
UKOSS: Pandemic Influenza in PregnancyObservationalNIHRUniversity of OxfordOpen20 March 2020
GenOMICCObservationalWellcome TrustNHS LothianOpen02 April 2020
Coronavirus infection in immunosuppressed childrenObservationalBritish Paediatric Allergy, Immunity and Infection GroupUNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUSTClosed02 April 2020
DIAMONDS SEARCH ObservationalEuropean CommissionImperial College of Science, Technology and MedicineOpen02 April 2020
What's the STORY ObservationalNIHR/UKRIUniversity of OxfordOpen06 April 2020
Virus WatchObservationalNIHR/UKRIUniversity College LondonOpen18 April 2020
Pregnancy and Neonatal Outcomes in COVID-19ObservationalNIHR/UKRIImperial College of Science, Technology and MedicineOpen18 April 2020
Neonatal complications of coronavirus disease (COVID-19)ObservationalNIHRUniversity of OxfordOpen21 April 2020
MERMAIDS - ARIObservationalEuropean CommissionUniversity of OxfordOpen07 May 2020
SIREN - SARS-COV2 immunity and reinfection evaluationObservationalPublic Health EnglandPublic Health EnglandOpen18 May 2020
FALCON C-19ObservationalNIHR/UKRI Manchester University NHS Foundation TrustOpen04 May 2020
RAPTOR C-19ObservationalNIHR/UKRIUniversity of OxfordOpen04 May 2020
VIVALDIObservationalDepartment of Health and Social CareUniversity College LondonOpen02 June 2020
COVID-HEARTObservationalnot availableLeeds Teaching Hospitals NHS TrustOpen04 June 2020
UK Coronavirus Immunology Consortium (CIC)ObservationalNIHR/UKRIUniversity of BirminghamOpen01 July 2020
PHOSP-COVIDObservational NIHR/UKRIUniversity of LeicesterOpen01 July 2020
C-MORE Capturing MultiORgan Effects of COVID-19ObservationalNIHR/UKRIUniversity of OxfordOpen04 June 2020
TraCK: Transmission of COVID-19 in KidsObservationalAction Medical ResearchImperial College of Science, Technology and MedicineOpen16 July 2020
NHS CHECKObservationalNIHR/UKRIKing's College LondonClosed05 August 2020
COVID-19 Infection SurveyObservationalOffice for National StatisticsUniversity of OxfordOpen20 August 2020
CLARITYObservationalF. Hoffmann-La Roche Ltd; Hull University Teadhing Hospitals NHS TrustRoyal Devon and Exeter NHS Foundation TrustClosednot available
AERATORObservationalNIHR/UKRINorth Bristol NHS TrustOpennot available
UK-REACHObservationalNIHR/UKRIUniversity of Leicester Open20 July 2020
Characterisation of COVID-19 long-term immune responseObservationalMedical Research CouncilUniversity of BristolClosed01 October 2020
RECAPObservationalOxford team: UKRI. Imperial team: Community Jameel (philanthropic) fundImperial College LondonOpen14 October 2020
FALCON C-19 (Workstream B)ObservationalNIHR / UKRIManchester University NHS Foundation TrustOpen04 May 2020
COVID-CNSObservationalMRC / UKRIUniversity of LiverpoolIn Setup21 December 2020
CO@h patient experience study (V1.0)ObservationalNIHRUniversity College LondonIn Setup29 January 2021
CoMMinSObservational/InterventionalNIHR/UKRIUniversity of BristolOpen05 August 2020
Rapid development of manufacturing processes for future production of adenovirus-vectored COVID19 vaccine at million-dose scalePre-clinicalNIHR/UKRIUniversity of Oxfordnot available11 March 2020
nCoV: Developing CoV-bnMABs for therapy of highly pathogenic coronaviruses including SARS-CoV-2Pre-clinicalNIHR/UKRInot availablePossible pre-clinical study11 March 2020
Repurposing FDA-Approved Drugs for Treatment of 2019-nCoV-induced DiseasePre-clinicalNIHR/UKRIQueens University Belfastnot available11 March 2020